Journal article
The benefits of ascorbate to protect healthy cells in the prevention and treatment of oncological diseases
Journal of applied biomedicine, Vol.18(1), pp.1-7
01/01/2020
DOI: 10.32725/jab.2020.003
PMID: 34907706
Abstract
Health status is determined by the balance of oxidants and antioxidants which protects healthy cells against the threat of internal and external risk factors. Antioxidants such as ascorbate (vitamin C, ascorbic acid) are of fundamental importance in this respect. Ascorbate neutralizes potential damage caused by cellular oxidative stress which may be the greatest risk of damage to healthy tissue. Cellular oxidative stress is mediated by external factors (e.g. psychological stress, physical exertion, drugs, various diseases, environmental pollution, preservatives, smoking, and alcohol) and internal factors (products of cellular metabolism induding reactive oxygen species). When the products of oxidative stress are not sufficiently neutralized, healthy cells are at risk for both mitochondrial and DNA damage. In the short term, cell function may deteriorate, while an increased production of proinflammatory cytokines over time may lead to the development of chronic inflammatory changes and diseases, induding cancer. Although pharmaceutical research continues to bring effective chemotherapeutic agents to the market, a limiting factor is often the normal tissue and organ toxicity of these substances, which leads to oxidative stress on healthy tissue. There is increasing interest and imperative to protect healthy tissues from the negative effects of radio-chemotherapeutic treatment. The action of ascorbate against the development of oxidative stress may justify its use not only in the prevention of carcinogenesis, but as a part of supportive or complementary therapy during treatment. Ascorbate (particularly when administered parentally at high doses) may have antioxidant effects that work to protect healthy cells and improve patient tolerability to some toxic radio-chemotherapy regimens. Additionally, ascorbate has demonstrated an immunomodulatory effect by supporting mechanisms essential to anti-tumor immunity. Intravenous administration of gram doses of vitamin C produce high plasma levels immediately, but the levels drop rapidly. Following oral vitamin C administration, plasma levels increase slowly to relatively low values, and then gradually decay. With an oral liposomal formulation, significantly higher levels are attainable than with standard oral formulations. Therefore, oral administration of liposomal vitamin C appears to be an optimal adjunct to intravenous administration. In this review, the basic mechanisms and clinical benefits of ascorbate as an antioxidant that may be useful as complementary therapy to chemotherapeutic regimens will be discussed.
Details
- Title: Subtitle
- The benefits of ascorbate to protect healthy cells in the prevention and treatment of oncological diseases
- Creators
- Pavel Klener - Charles Univ Prague, Prague, Czech RepublicMatthew Scott Alexander - Univ Iowa, Dept Surg, Carver Coll Med, Iowa City, IA USAJoseph John Cullen - University of IowaVera Stejskal - Univ Stockholm, Wenner Gren Ctr, Dept Immunol, Stockholm, SwedenJiri Sliva - Charles Univ Prague, Fac Med 3, Dept Pharmacol, Prague, Czech RepublicLucie Kotlarova - InPharmClin, Dept Pharmacol, Prague, Czech RepublicPavel Kostiuk - Edukafarm, Dept Pharmacol, Prague, Czech RepublicZdenek Prochazka - Edukafarm, Dept Pharmacol, Prague, Czech RepublicMarta Kucerova - Hosp Jablonec Nad Nisou, Dept Oncol, Jablonec Nad Nisou, Czech Republic
- Resource Type
- Journal article
- Publication Details
- Journal of applied biomedicine, Vol.18(1), pp.1-7
- DOI
- 10.32725/jab.2020.003
- PMID
- 34907706
- NLM abbreviation
- J Appl Biomed
- ISSN
- 1214-021X
- eISSN
- 1214-0287
- Publisher
- Univ South Bohemia
- Number of pages
- 7
- Grant note
- CA148062; CA184051 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 01/01/2020
- Academic Unit
- Surgery; Radiation Oncology
- Record Identifier
- 9984312986902771
Metrics
16 Record Views